Ironwood Pharmaceuticals, Inc. (IRWD)
4.42
+0.15
(+3.51%)
USD |
NASDAQ |
Sep 02, 14:16
Ironwood Pharmaceuticals Net Income (TTM) : 129.87M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 129.87M |
| March 31, 2026 | 102.18M |
| December 31, 2025 | 24.02M |
| September 30, 2025 | 28.55M |
| June 30, 2025 | -7.885M |
| March 31, 2025 | -32.34M |
| December 31, 2024 | 0.88M |
| September 30, 2024 | -3.121M |
| June 30, 2024 | 7.183M |
| March 31, 2024 | -1.081B |
| December 31, 2023 | -1.032B |
| September 30, 2023 | -980.95M |
| June 30, 2023 | -944.58M |
| March 31, 2023 | 181.98M |
| December 31, 2022 | 175.06M |
| September 30, 2022 | 167.57M |
| June 30, 2022 | 173.10M |
| March 31, 2022 | 527.32M |
| December 31, 2021 | 528.45M |
| September 30, 2021 | 530.28M |
| June 30, 2021 | 508.86M |
| March 31, 2021 | 142.76M |
| December 31, 2020 | 106.18M |
| September 30, 2020 | 110.83M |
| June 30, 2020 | 97.06M |
| Date | Value |
|---|---|
| March 31, 2020 | 84.13M |
| December 31, 2019 | 58.94M |
| September 30, 2019 | 19.46M |
| June 30, 2019 | -153.01M |
| March 31, 2019 | -189.43M |
| December 31, 2018 | -210.73M |
| September 30, 2018 | -207.02M |
| June 30, 2018 | -87.49M |
| March 31, 2018 | -107.58M |
| December 31, 2017 | -116.94M |
| September 30, 2017 | -142.53M |
| June 30, 2017 | -143.43M |
| March 31, 2017 | -120.91M |
| December 31, 2016 | -81.71M |
| September 30, 2016 | -82.24M |
| June 30, 2016 | -96.43M |
| March 31, 2016 | -122.74M |
| December 31, 2015 | -142.67M |
| September 30, 2015 | -166.28M |
| June 30, 2015 | -160.88M |
| March 31, 2015 | -173.21M |
| December 31, 2014 | -189.62M |
| September 30, 2014 | -203.96M |
| June 30, 2014 | -223.74M |
| March 31, 2014 | -228.54M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Rigel Pharmaceuticals, Inc. | 321.91M |
| AbbVie, Inc. | 6.274B |
| Marker Therapeutics, Inc. | -8.707M |
| Theriva Biologics, Inc. | -11.62M |
| Fortress Biotech, Inc. | 141.19M |